Physician profile
Karen Kish
NPI 1124015953
$661.57
in general payments reported to CMS, 2019-2025
17 companies · $17.01 in 2025
The $17.01 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $497 · 2020: $22.26 · 2021: $60.95 · 2022: $50.72 · 2024: $13.80 · 2025: $17.01.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $30.81.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $30.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $118.66 | 2019-2022 | |
| Roche Diagnostics Corporation | $77.24 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $70.11 | 2019 | |
| Pfizer INC. | $53.51 | 2019-2024 | |
| Daiichi Sankyo INC. | $49.63 | 2019 | |
| Merck Sharp & Dohme LLC | $44.75 | 2019 | |
| Duchesnay USA Incorporated | $39.31 | 2019 | |
| Therapeuticsmd, INC. | $38.47 | 2019 | |
| Dysis Medical, INC. | $37.02 | 2021 | |
| Abbvie INC. | $23.93 | 2021 | |
| Acessa Health INC. | $18.13 | 2019 | |
| Avanos Medical | $17.68 | 2019 | |
| Collegium Pharmaceutical, INC. | $17.01 | 2025 | Jornay Pm |
| Vertical Pharmaceuticals, LLC | $14.39 | 2019 | |
| Aspira Women'S Health INC | $14.31 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $13.85 | 2019 | |
| Avion Pharmaceuticals | $13.57 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karen Kish listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.